Valentina Di Vito
Overview
Explore the profile of Valentina Di Vito including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
83
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Laffi A, Lania A, Ragni A, Di Vito V, Liccardi A, Rubino M, et al.
Cancers (Basel)
. 2023 May;
15(8).
PMID: 37190131
Purpose: to collect data from real-life experiences of the management of type 3 g-NETs and identify possible prognostic factors that may impact the decision-making process. Methods: We performed a systematic...
2.
Fanciulli G, Modica R, La Salvia A, Campolo F, Florio T, Mikovic N, et al.
Cancers (Basel)
. 2022 Aug;
14(16).
PMID: 36010987
Neuroendocrine neoplasms (NENs) are a heterogeneous group of tumors with variable clinical presentation and prognosis. Surgery, when feasible, is the most effective and often curative treatment. However, NENs are frequently...
3.
Feola T, Centello R, Sesti F, Puliani G, Verrico M, Di Vito V, et al.
Pancreas
. 2022 Apr;
51(2):e25-e27.
PMID: 35404907
No abstract available.
4.
Puliani G, Di Vito V, Feola T, Sesti F, Centello R, Pandozzi C, et al.
Neuroendocrinology
. 2021 Sep;
112(6):523-536.
PMID: 34515175
The NETest is a standardized and reproducible liquid biopsy for neuroendocrine tumors (NETs). It evaluates the expression of 51 NET genes by real-time polymerase chain reaction, providing an accurate molecular...
5.
Sesti F, Feola T, Puliani G, Centello R, Di Vito V, Bagni O, et al.
Front Oncol
. 2021 Jul;
11:677983.
PMID: 34221997
Background: Paragangliomas (PGLs) are neuroendocrine neoplasms arising from chromaffin cells of sympathetic or parasympathetic paraganglia. Systemic therapies have been used only in metastatic PGLs. Antiangiogenic agents, such as sunitinib, could...
6.
Feola T, Centello R, Sesti F, Puliani G, Verrico M, Di Vito V, et al.
Cancers (Basel)
. 2021 Apr;
13(6).
PMID: 33809007
Background: Highly proliferative (G3) neuroendocrine neoplasms are divided into well differentiated tumors (NETs) and poorly differentiated carcinomas (NECs), based on the morphological appearance. This systematic review aims to evaluate the...
7.
Gallo M, Campione S, Di Vito V, Fortunati N, Lo Calzo F, Messina E, et al.
Front Endocrinol (Lausanne)
. 2021 Feb;
11:610230.
PMID: 33584543
Neuroendocrine breast tumors represent a rare subtype of breast cancer, accounting for less than 1% of all neuroendocrine neoplasms. Starting from their pathology definition, and going through their prevalence, prognosis...
8.
Scandurra C, Modica R, Maldonato N, Dolce P, Dipietrangelo G, Centello R, et al.
J Clin Endocrinol Metab
. 2020 Oct;
106(1):e316-e327.
PMID: 33084861
Context: Although health-related quality of life (HRQoL) is a fundamental outcome in oncological clinical trials, its evaluation in the neuroendocrine neoplasm (NEN) research field is still limited. Objectives: This study...
9.
Feola T, Puliani G, Sesti F, Modica R, Biffoni M, Di Gioia C, et al.
Front Endocrinol (Lausanne)
. 2020 Aug;
11:397.
PMID: 32765421
Laryngeal neuroendocrine neoplasms (NENs) are a rare group of NENs of the neck, which commonly show immunostaining for calcitonin. Laryngeal NENs with calcitonin hypersecretion and lymph node metastases represent a...